These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24168370)

  • 21. CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization.
    Xu H; Hodder AN; Yan H; Crewther PE; Anders RF; Good MF
    J Immunol; 2000 Jul; 165(1):389-96. PubMed ID: 10861076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Review of Human
    Heide J; Vaughan KC; Sette A; Jacobs T; Schulze Zur Wiesch J
    Front Immunol; 2019; 10():397. PubMed ID: 30949162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of HLA-DRB1 alleles on antibody responses to PfCP-2.9-immunized and naturally infected individuals.
    Zhang Q; Xue X; Xu X; Wang C; Chang W; Pan W
    J Clin Immunol; 2009 Jul; 29(4):454-60. PubMed ID: 19247821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled Human Malaria Infection (CHMI) differentially affects cell-mediated and antibody responses to CSP and AMA1 induced by adenovirus vaccines with and without DNA-priming.
    Sedegah M; Hollingdale MR; Farooq F; Ganeshan H; Belmonte M; Huang J; Abot E; Limbach K; Chuang I; Tamminga C; Epstein JE; Villasante E
    Hum Vaccin Immunother; 2015; 11(11):2705-15. PubMed ID: 26292027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human CD8+ T cells mediate protective immunity induced by a human malaria vaccine in human immune system mice.
    Li X; Huang J; Zhang M; Funakoshi R; Sheetij D; Spaccapelo R; Crisanti A; Nussenzweig V; Nussenzweig RS; Tsuji M
    Vaccine; 2016 Aug; 34(38):4501-4506. PubMed ID: 27502569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine.
    Longley RJ; Halbroth BR; Salman AM; Ewer KJ; Hodgson SH; Janse CJ; Khan SM; Hill AVS; Spencer AJ
    Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28031267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine.
    McCoy ME; Golden HE; Doll TA; Yang Y; Kaba SA; Zou X; Gerbasi VR; Burkhard P; Lanar DE
    Malar J; 2013 Apr; 12():136. PubMed ID: 23607541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-lived effector CD8 T cells induced by genetically attenuated malaria parasite vaccination express CD11c.
    Cooney LA; Gupta M; Thomas S; Mikolajczak S; Choi KY; Gibson C; Jang IK; Danziger S; Aitchison J; Gardner MJ; Kappe SH; Wang R
    Infect Immun; 2013 Nov; 81(11):4171-81. PubMed ID: 23980113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP1
    Obaldia N; Stockelman MG; Otero W; Cockrill JA; Ganeshan H; Abot EN; Zhang J; Limbach K; Charoenvit Y; Doolan DL; Tang DC; Richie TL
    Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28179404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmodium vivax but Not Plasmodium falciparum Blood-Stage Infection in Humans Is Associated with the Expansion of a CD8+ T Cell Population with Cytotoxic Potential.
    Burel JG; Apte SH; McCarthy JS; Doolan DL
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005031. PubMed ID: 27930660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel sporozoite-based ELISpot assay to assess frequency of parasite-specific B cells after vaccination with irradiated sporozoites.
    Atre T; Robinson TM; Savransky T; Dutta S; Epstein JE; Bergmann-Leitner ES
    Malar J; 2019 May; 18(1):186. PubMed ID: 31142328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.
    Bergmann ES; Ballou RW; Krzych U
    Cell Immunol; 1997 Sep; 180(2):143-52. PubMed ID: 9341744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara.
    Thera MA; Coulibaly D; Kone AK; Guindo AB; Traore K; Sall AH; Diarra I; Daou M; Traore IM; Tolo Y; Sissoko M; Niangaly A; Arama C; Baby M; Kouriba B; Sissoko MS; Sagara I; Toure OB; Dolo A; Diallo DA; Remarque E; Chilengi R; Noor R; Sesay S; Thomas A; Kocken CH; Faber BW; Imoukhuede EB; Leroy O; Doumbo OK
    Malar J; 2016 Aug; 15(1):442. PubMed ID: 27577237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
    Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
    J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites.
    Nardin E; Munesinghe YD; Moreno A; Clavijo P; Calle MC; Edelman R; Davis J; Herrington D; Nussenzweig RS
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():223-7. PubMed ID: 1364202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deciphering the Plasmodium falciparum malaria-specific CD4+ T-cell response: ex vivo detection of high frequencies of PD-1+TIGIT+ EXP1-specific CD4+ T cells using a novel HLA-DR11-restricted MHC class II tetramer.
    Schulte S; Heide J; Ackermann C; Peine S; Ramharter M; Mackroth MS; Woost R; Jacobs T; Schulze Zur Wiesch J
    Clin Exp Immunol; 2022 Apr; 207(2):227-236. PubMed ID: 35020841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles.
    Doolan DL; Southwood S; Chesnut R; Appella E; Gomez E; Richards A; Higashimoto YI; Maewal A; Sidney J; Gramzinski RA; Mason C; Koech D; Hoffman SL; Sette A
    J Immunol; 2000 Jul; 165(2):1123-37. PubMed ID: 10878392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria.
    Malkin EM; Diemert DJ; McArthur JH; Perreault JR; Miles AP; Giersing BK; Mullen GE; Orcutt A; Muratova O; Awkal M; Zhou H; Wang J; Stowers A; Long CA; Mahanty S; Miller LH; Saul A; Durbin AP
    Infect Immun; 2005 Jun; 73(6):3677-85. PubMed ID: 15908397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference.
    Forbes EK; Biswas S; Collins KA; Gilbert SC; Hill AV; Draper SJ
    J Immunol; 2011 Oct; 187(7):3738-50. PubMed ID: 21876036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Th1 immune response to Plasmodium falciparum circumsporozoite protein is boosted by adenovirus vectors 35 and 26 with a homologous insert.
    Radosevic K; Rodriguez A; Lemckert AA; van der Meer M; Gillissen G; Warnar C; von Eyben R; Pau MG; Goudsmit J
    Clin Vaccine Immunol; 2010 Nov; 17(11):1687-94. PubMed ID: 20826614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.